Biogen (BIIB)

Company Ticker Sector | Industry Quality PAR
Biogen BIIB Healthcare | Biotechnology 77 15.4%
Current Price (09/20) $238.79
CAPS Rating (Rate this stock on CAPS) Foolcaps 4
Expected Income Statement
Current Sales 13,886.8
Sales Growth Forecast 6.9%
Net Profit Margin 37.8%
Projected Shares Outstanding 180.08
EPS - Five year Forecast $40.64
Average P/E Ratio 12.0
Projected Average Price $487.70
Price Appreciation (Annualized) 15.4%
Annual Dividend Yield 0.0%
Projected Annual Return 15.4%
Quality
Financial Strength 84 21.0
EPS Stability 74 18.5
Industry Sales Growth Rate 16.5% 5.2
Industry Net Profit Margin 29.0% 16.3
Calculated Quality Rating 61.0
Fool CAPS

Total Players

992 Outperforms
71 Underperforms
 

All-Stars (243)

231 Outperforms (95%)
12 Underperforms
 
Fundamental Data Updated: 07/05/2019

MIPAR 8.8%  
Sweet Spot 13.8% - 18.8%  

Top In Biotechnology

Ticker Quality PAR
JAZZ 94 16.7%
RGEN 72 19.1%
BSTC 77 16.0%
BIIB 77 15.4%
CELG 63 19.9%

Top In Healthcare

Ticker Quality PAR
ALGN 96 17.7%
JAZZ 94 16.7%
UNH 97 13.7%
ABBV 88 15.0%
BMY 93 23.9%